Literature DB >> 2543747

Use of human adenovirus-based vectors for antigen expression in animals.

L Prevec1, M Schneider, K L Rosenthal, L W Belbeck, J B Derbyshire, F L Graham.   

Abstract

An infectious recombinant human adenovirus type 5 (Ad5) vector, AdG12, which carries the glycoprotein gene of vesicular stomatitis virus (VSV) and expresses that gene in cultured HeLa cells was used to examine the host range of insert expression by human Ad vectors. The VSV glycoprotein was expressed in bovine, canine and murine cells when infected with AdG12 in culture. These cell lines are respectively permissive, non-permissive and semi-permissive for human Ad5 replication. Administration of the AdG12 vector to calves, piglets or dogs by either the subcutaneous or oral route resulted in the production of high titres of neutralizing antibodies to VSV. Mice injected intraperitoneally with the vector produced neutralizing antibodies and were protected against subsequent intravenous challenge with normally lethal doses of VSV. This work demonstrates the utility of human adenoviral vectors for antigen expression in a number of non-human cell lines and for the induction of an immune response to the delivered antigen in a number of species.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543747     DOI: 10.1099/0022-1317-70-2-429

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  B7-1 gene transfer into human cancer cells by infection with an adenovirus-B7 (Ad-B7) expression vector.

Authors:  S Dessureault; F Graham; S Gallinger
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

4.  Recombinant adenovirus vectors expressing interleukin-5 and -6 specifically enhance mucosal immunoglobulin A responses in the lung.

Authors:  T A Braciak; W S Gallichan; F L Graham; C D Richards; A J Ramsay; K L Rosenthal; J Gauldie
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

5.  Studies on the stability of a human adenovirus-rabies recombinant vaccine.

Authors:  K K Kalicharran; V S Springthorpe; S A Sattar
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

6.  Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.

Authors:  Y Ilan; R Prakash; A Davidson; G Droguett; M S Horwitz; N R Chowdhury; J R Chowdhury
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  Induction of mucosal immunity in cotton rats to haemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus.

Authors:  M E Baca-Estrada; X Liang; L A Babiuk; D Yoo
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

8.  Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.

Authors:  J M Torres; C Alonso; A Ortega; S Mittal; F Graham; L Enjuanes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Methods for construction of adenovirus vectors.

Authors:  F L Graham; L Prevec
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

10.  Potential viral vectors for the stimulation of mucosal antibody responses against enteric viral antigens in pigs.

Authors:  T Tuboly; E Nagy; J B Derbyshire
Journal:  Res Vet Sci       Date:  1993-05       Impact factor: 2.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.